SpliceBio

📍 Barcelona, Spain👥 39 employees💰 Last funded Feb 2022
Biotechnology🌐 splice.bio
Website LinkedIn
SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Spain
3
Netherlands
1
Investor activity2019–2022 · investors recorded per year
201912020120222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in SpliceBio?
SpliceBio has 4 investors on record on gritt.io.
When did SpliceBio last raise funding?
The most recent investment in SpliceBio recorded on gritt.io was in February 2022.
What industry is SpliceBio in?
SpliceBio operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is SpliceBio based?
SpliceBio is headquartered in Barcelona, Spain.